Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 2 I, 2000, Pages 578-585

  Virchow J C , Jr ^a   Prasse, A ^a   Naya, I ^a   Summerton, L ^a   Harris, A ^a   De Backer, W ^a   Deman, R ^a   Leloup, A ^a   Sibille, Y ^a   Thiriaux, J ^a   Verhoye, P ^a   Patel, P ^a   Godard, P ^a   Caillaud, D ^a   Fournier, M ^a   Guerin, J C ^a   Leynadier, L ^a   Pauli, G ^a   Tonnel, A ^a   Dunkhase, G ^a   Feussner, W ^a   Gordt, U ^a   Gunsberg, K ^a   Korduan, M ^a   Linnhoff, A ^a   Possner, S ^a   Habich, G ^a   Jurgens, U ^a   Molitor, S J ^a   Olbrich, H ^a   Otto, M ^a   Overlack, A ^a   Riffelmann, F W ^a   Szasz, I ^a   Virchow, J C ^a   Ciani, C ^a   Dal Negro, R ^a   Dardes, N ^a   Giuntini, C ^a   Grassi, C ^a   Marazzini, L ^a   Neri, M ^a   Ruggeri, S ^a   Vagliasindi, M ^a   Valerio, G ^a   Bantje, T H ^a   Greefhorst, A P ^a   Van Harreveld, A J ^a   Hekking, P R ^a   De Munck, A J ^a   Pieters, W R ^a   Damste, H E S ^a   Sips, A P ^a   Westbroek, J ^a   Eivindsson, A ^a   Gloersen, E ^a   Hannaes, O C ^a   Lier, P A ^a   Jenssen, H ^a   Langaker, K E ^a   Overaa, O ^a   Ringdal, N ^a   Sundset, A ^a   Droszcz, W ^a   Kus, J ^a   Alvarez, J L ^a   Basomba, A ^a   Castillo, J ^a   Crespo, J A ^a   Izquierdo, J L ^a   Morera, J ^a   Ripolles, F ^a   Candeira, S R ^a   Sastre, J ^a   Verea, H ^a   Ekstrom, T ^a   Lowhagen, O ^a   Ostling, E ^a   Stahlenheim, G ^a   Tilling, B ^a   Ziegler, J ^a   Barber, P ^a   Hutchcroft, B J ^a   Millar, A ^a   Spence, D ^a   Taylor, I K ^a   Winning, A J ^a   more..

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; CORTICOSTEROID; ZAFIRLUKAST;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE CONTROL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033837039     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.2.9905041     Document Type: Article

References (36)

1. The preclinical pharmacology of ICI 204,219: A peptide leukotriene antagonist
2. 4, increase the release of mucus from human airways in vitro
3. 4 and granulocytic infiltration into asthmatic airways
4. 4 receptor antagonist
5. 4-receptor antagonist
6. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction
7. Effect of cysteinyl-leukotriene receptor antagonist ICI 204,219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects
8. The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air
9. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin
10. Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonist
11. 4) receptor antagonist (MK-571) in patients with asthma
12. Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma: A randomized controlled trial
13. 4 receptor antagonist, in subjects with bronchial asthma
14. Effect of zafirlukast (Accolate) on cellular mediators of inflammation: Bronchoalveolar lavage fluid findings after segmental antigen challenge
15. Effect of chronic 5-lipoxygenase inhibition on airway hyperresponsiveness in asthmatic subjects
16. Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid
17. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
18. Zafirlukast for symptomatic mild-to-moderate asthma: A 13-week multicenter study
19. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids
20. Effect of inhaled formoterol and budesonide on exacerbations of asthma
21. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma
22. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics
23. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year
24. High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma
25. Zafirlukast in clinical practice: Results of The Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT) in patients with asthma
26. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma
27. 4 and methacholine on sputum cell differentials in asthma
28. Montelukast reduces airway eosinophilic inflammation in asthma: A randomized, controlled trial
29. Effect of oral prednisone on airway inflammatory mediators in atopic asthma
30. In vivo and in vitro effects of glucocorticosteroids on arachidonic acid metabolism and monocyte function in nonasthmatic humans
31. 4 excretion
32. Inhibition of eicosanoid biosynthesis by glucocorticoids in humans
33. 4 from the urine of patients with airway obstruction
34. Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids